APA (7th ed.) Citation

Janas, L., Stachowiak, G., Glowacka, E., Piwowarczyk, I., Kajdos, M., Soja, M., . . . Nowak, M. (2024). The use of CA125, human epididymis protein 4 (HE4), risk of ovarian malignancy algorithm (ROMA), risk of malignancy index (RMI) and subjective assessment (SA) in preoperative diagnosing of ovarian tumors. Ginekologia polska, 95(5), 321-327. https://doi.org/10.5603/GP.a2022.0144

Chicago Style (17th ed.) Citation

Janas, Lukasz, Grzegorz Stachowiak, Ewa Glowacka, Iwona Piwowarczyk, Magdalena Kajdos, Malwina Soja, Martyna Masternak, and Marek Nowak. "The Use of CA125, Human Epididymis Protein 4 (HE4), Risk of Ovarian Malignancy Algorithm (ROMA), Risk of Malignancy Index (RMI) and Subjective Assessment (SA) in Preoperative Diagnosing of Ovarian Tumors." Ginekologia Polska 95, no. 5 (2024): 321-327. https://doi.org/10.5603/GP.a2022.0144.

MLA (9th ed.) Citation

Janas, Lukasz, et al. "The Use of CA125, Human Epididymis Protein 4 (HE4), Risk of Ovarian Malignancy Algorithm (ROMA), Risk of Malignancy Index (RMI) and Subjective Assessment (SA) in Preoperative Diagnosing of Ovarian Tumors." Ginekologia Polska, vol. 95, no. 5, 2024, pp. 321-327, https://doi.org/10.5603/GP.a2022.0144.